[HTML][HTML] A systematic review and meta‐analysis of venous thrombosis risk among users of combined oral contraception

MV Dragoman, NK Tepper, R Fu… - … of Gynaecology and …, 2018 - ncbi.nlm.nih.gov
Background Combined oral contraceptives (COC s) containing various progestogens could
be associated with differential risks for venous thromboembolism (VTE). Objective To …

[HTML][HTML] Estrogen-progestins and progestins for the management of endometriosis

P Vercellini, L Buggio, N Berlanda, G Barbara… - Fertility and …, 2016 - Elsevier
Endometriosis is characterized by frequent recurrences of symptoms and lesions even after
extirpative surgery. Because medical therapies control but do not cure the disease, long …

[HTML][HTML] Combined hormonal contraception and the risk of venous thromboembolism: a guideline

S Pfeifer, S Butts, D Dumesic, G Fossum, C Gracia… - Fertility and sterility, 2017 - Elsevier
While venous thromboembolism (VTE) is rare in young women of reproductive age,
combined oral contraceptives increase the risk of VTE. In the patient in whom combined …

Birth control pills and thrombotic risks: differences of contraception methods with and without estrogen

H Rott - Hämostaseologie, 2019 - thieme-connect.com
In Germany one-third of the women in fertile age use combined oral contraceptives (COCs),
which consist mostly of ethinylestradiol (EE) and a synthetic progestin. Older COCs with …

Risk of venous thromboembolism in women taking the combined oral contraceptive: A systematic review and meta-analysis

D Bateson, BE Butcher, C Donovan… - Australian family …, 2016 - search.informit.org
Background: Much scientific, media and patient interest surrounds the risk of venous
thromboembolism (VTE) in women taking combined oral contraceptives (COCs). Objectives …

[HTML][HTML] Which adverse effects influence the dropout rate in selective serotonin reuptake inhibitor (SSRI) treatment? Results for 50,824 patients

K Kostev, J Rex, T Eith, C Heilmaier - GMS German Medical …, 2014 - ncbi.nlm.nih.gov
Background: Nowadays, selective serotonin reuptake inhibitors (SSRIs) are the most
frequently prescribed antidepressants due to their superior clinical efficacy, effectiveness …

Sex hormones and venous thromboembolism–from contraception to hormone replacement therapy

J Beyer-Westendorf, R Bauersachs, V Hach-Wunderle… - Vasa, 2018 - econtent.hogrefe.com
The use of sex hormones such as combined oral contraceptives (COC) or hormone
replacement therapy (HRT) increases the risk for venous thromboembolism (VTE) …

Метаболические эффекты комбинированной гормональной контрацепции и риск тромботических осложнений

ИВ Кузнецова - Акушерство и гинекология, 2016 - elibrary.ru
Цель исследования. Провести систематизированный обзор литературных данных
относительно влияния на риск венозного и артериального тромбоза комбинированных …

Dienogest versus norethisterone acetate in management of endometrial hyperplasia without atypia

EF Girbash, HE Sherif, AM Radwan… - Archives of gynecology …, 2023 - Springer
Objectives To compare the effectiveness of dienogest (DIE) and norethisterone acetate
(NETA) regimens in the treatment of endometrial hyperplasia (EH) without atypia. Methods …

Drospirenone‐containing oral contraceptive pills and the risk of venous thromboembolism: a systematic review of observational studies

N Larivée, S Suissa, F Khosrow‐Khavar… - … Journal of Obstetrics …, 2017 - Wiley Online Library
Background The effects of fourth‐generation drospirenone‐containing combined oral
contraceptives (COC s) on the risk of venous thromboembolism (VTE) are controversial …